Viking Therapeutics among potential buyout candidates: Oppenheimer
[ad_1]
Viking Therapeutics among potential buyout candidates: Oppenheimer
[ad_2]
[ad_1] Columbia Acorn Fund Adv [ad_2]
[ad_1] Taiwan Semiconductor Manufacturing Company GAAP EPS of $2.24 beats by $0.01, revenue of $26.88B beats by $890M [ad_2]
[ad_1] Adaptive Biotechnologies and NeoGenomics partner to expand access to disease monitoring for blood cancer patients [ad_2]
[ad_1] Grandbrothers Johnson & Johnson (NYSE:JNJ) has received Priority Review designation from the FDA for the Biologics License Application for its drug nipocalimab in the treatment of antibody-positive patients with generalized myasthenia gravis. Nipocalimab was also recently granted Breakthrough Therapy Designation by [ad_2]
[ad_1] Establishment Labs falls 13%, CEO to step down [ad_2]
[ad_1] FCPT acquires Burger King property for $1.7M [ad_2]